Bromide

Bromide

SCHEMBL3276509

Br.Br.COCCN(CCOC)c1ccc2c(c1)OCCNC2

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
ADRA2A known ✓ P08913 1/20 0.33
ADRA2B known ✓ P18089 1/20 0.33
ADRA2C known ✓ P18825 1/20 0.33
ADRA1D known ✓ P25100 1/20 0.33
ADRA1A known ✓ P35348 1/20 0.33
ADRA1B known ✓ P35368 1/20 0.33
S1PR1 P21453 2/20 0.35
GPX4 P36969 1/20 0.31
CD274 Q9NZQ7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3276410 0.81 ALDH1A1 (0.40) S1PR1ADRA2AADRA2BADRA2CADRA1D
Hydrochloric Acid SCHEMBL3275985 0.80 ALDH1A1 (0.43) S1PR1ADRA2AADRA2BADRA2CADRA1D
SCHEMBL3275925 0.75 ADRA2A (0.36) S1PR1ADRA2AADRA2BADRA2CADRA1D
SCHEMBL3280267 0.75 S1PR1 (0.40) S1PR1ADRA2AADRA2BADRA2CADRA1D
Hydrochloric Acid SCHEMBL3280505 0.74 ADRA2A (0.35) S1PR1ADRA2AADRA2BADRA2CADRA1D
Hydrochloric Acid SCHEMBL3276741 0.74 S1PR1 (0.39) S1PR1ADRA2AADRA2BADRA2CADRA1D
SCHEMBL6833691 0.71 KCNH2 (0.48) S1PR1ADRA2AADRA2BADRA2CCD274
SCHEMBL1886713 0.69 FABP6 (0.45) S1PR1ADRA2ACD274
SCHEMBL22131607 0.69 ALDH1A1 (0.50) S1PR1ADRA2AADRA2BADRA2CCD274
SCHEMBL3276234 0.67 RIPK1 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2123644-B1 BENZOXAZEPINE DERIVATIVES AND USE THEREOF TAKEDA PHARMACEUTICAL (JP) 2014-12-17 EP disclosed
US-8247403-B2 Benzoxazepine derivatives and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-08-21 US disclosed
US-20100087418-A1 BENZOXAZEPINE DERIVATIVES AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED 2010-04-08 US disclosed
EP-2123644-A1 BENZOXAZEPINE DERIVATIVES AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2009-11-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087418-A1 BENZOXAZEPINE DERIVATIVES AND USE THEREOF HTR2C, HTR5A, HTR2B ADRA2A 68/4885ADRA2B 56/4885ADRA2C 17/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.